Horizon Therapeutics

KRYSTEXXA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / KRYSTEXXA – J2507

Manufacturer:

Horizon Therapeutics

Name:

KRYSTEXXA

HCPCS Code Descriptor:

Injection, pegloticase, 1 mg

Category:

J Code

HCPCS:

J2507

NDC(s):

75987-0080-10

Primary Type:

Immunology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

KRYSTEXXA is an Immunology drug manufactured by Horizon Therapeutics and administered via the Intravenous route of administration. The J Code: J2507 is aligned to the drug KRYSTEXXA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/12

HCPCS Effective Date:

1/1/12

HCPCS Short Description:

Pegloticase injection

Billing and Coding Guide:

https://www.krystexxahcp.com/pdf/ICD10BasicsforPayers20140819.pdf, https://www.hzndocs.com/KRYSTEXXA-Coding-Guide.pdf

Patient Assistance:

https://www.krystexxahcp.com/rheumatology/